Trial
NCT01283321
RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
CSL Behring
Condition
Heart Valve Disease
Intervention
Human fibrinogen concentrate
Why stopped
Insufficient funding to complete total projected enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-06-21